ClinicalTrials.Veeva
Menu

Find clinical trials for Leukemia in Aurora, CO

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Myeloid Leukemia
Acute Myeloid Leukemia
Lymphoid Leukemia
B-Cell Chronic Lymphocytic Leukemia
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Lymphoma
Myelodysplastic Syndromes

Leukemia trials near Aurora, CO, USA:

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation (AUGMENT-101)

Phase 2 dose (RP2D) of revumenib in participants with acute leukemia.In Phase 2, participants will be enrolled in 3 indication-specific expa...

Enrolling
Acute Leukemia of Ambiguous Lineage
Mixed Phenotype Acute Leukemia
Drug: revumenib
Drug: cobicistat

Phase 1, Phase 2

Syndax Pharmaceuticals
Syndax Pharmaceuticals

Aurora, Colorado, United States and 56 other locations

NMS-03597812 as single agent in Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) patients who have exhausted standard treatment, includi...

Enrolling
Relapsed/Refractory Acute Myeloid Leukemia
Drug: NMS-03597812

Phase 1

Nerviano Medical Sciences

Aurora, Colorado, United States and 5 other locations

This study aims to treat non-elderly adult patients, who were previously untreated for acute myeloid leukemia, using venetoclax and azacitid...

Active, not recruiting
Acute Myeloid Leukemia
Drug: Venetoclax
Drug: Azacitidine

Phase 2

University of Colorado Denver (CU Denver)
University of Colorado Denver (CU Denver)

Aurora, Colorado, United States

GDX012 is a novel cell therapy developed for the treatment of certain types of cancer, including Acute Myeloid Leukemia (AML). The main aims...

Enrolling
Leukemia
Drug: GDX012
Drug: Chemotherapy Agents

Phase 1, Phase 2

Takeda
Takeda

Denver, Colorado, United States and 13 other locations

chemotherapy regimen for the treatment of B-cell acute lymphoblastic leukemia. Part 1 of the study will optimize the dose of study drug (rux...

Active, not recruiting
Leukemia
Drug: Methotrexate
Drug: Thioguanine

Phase 2

Incyte
Incyte

Aurora, Colorado, United States of America and 110 other locations

A Phase 1 first-in-human dose-escalation and dose-expansion study of BMF-500, an oral FLT3 inhibitor, in adult patients with acute leukemia....

Enrolling
Acute Myeloid Leukemia
Drug: BMF-500

Phase 1

Biomea Fusion

Denver, Colorado, United States and 22 other locations

People with acute myeloid leukemia (AML) are usually treated with chemotherapy. Some people with AML have a changed FLT3 gene which causes l...

Enrolling
Acute Myeloid Leukemia (AML)
FLT3-mutated Acute Myeloid Leukemia
Drug: Azacitidine
Drug: Venetoclax

Phase 1, Phase 2

Astellas
Astellas

Denver, Colorado, United States and 19 other locations

This is a Phase 1/2, multicenter, open-label study to evaluate the safety and efficacy of BEAM-201 in patients with relapsed/refractory T-ALL or T-LL...

Active, not recruiting
T-Cell Lymphoblastic Leukemia/Lymphoma
Lymphoblastic Leukemia
Biological: BEAM-201

Phase 1, Phase 2

Beam Therapeutics

Denver, Colorado, United States and 9 other locations

This study will evaluate the safety and tolerability of oral KPT-9274 for the treatment of patients with relapsed or refractory acute myeloid leukemia...

Enrolling
Acute Myeloid Leukemia Refractory
Acute Myeloid Leukemia, in Relapse
Drug: KPT-9274

Phase 1

University of Colorado Denver (CU Denver)
University of Colorado Denver (CU Denver)

Aurora, Colorado, United States and 1 other location

participants with previously treated chronic phase - chronic myeloid leukemia (CP-CML).The study has two parts: Part 1 of the trial (Dose Es...

Enrolling
Chronic Myeloid Leukemia
Chronic Myeloid Leukemia, Chronic Phase
Drug: TERN-701

Phase 1

Terns Pharmaceuticals

Lone Tree, Colorado, United States and 39 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems